GlassScriptPhysician profile
Christopher C Breuder
NPI 1730361437
$5,476.56
in general payments reported to CMS, 2019-2025
38 companies · $546 in 2025
The $546 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $876 · 2020: $633 · 2021: $1,164 · 2022: $745 · 2023: $913 · 2024: $599 · 2025: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,058.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $562.34 | 2019-2025 | Arexvy, Shingrix, Bexsero |
| Pfizer INC. | $520.48 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $478.45 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $467.78 | 2019-2025 | Ozempic, Rybelsus |
| Dexcom, INC. | $277.38 | 2022-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Boehringer Ingelheim Pharmaceuticals, INC. | $268.80 | 2019-2024 | Jardiance |
| Lilly USA, LLC | $250.44 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novartis Pharmaceuticals Corporation | $232.48 | 2019 | |
| Exact Sciences Corporation | $217.44 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $203.98 | 2019-2024 | Gardasil 9, Capvaxive, Gardasil |
| Abbvie INC. | $190.59 | 2021-2023 | Synthroid |
| Allergan, INC. | $161.75 | 2019-2020 | |
| Genentech USA, INC. | $151.38 | 2020-2021 | |
| Edwards Lifesciences Corporation | $141.63 | 2023 | Sapien 3 Ultra Resilia |
| Teva Pharmaceuticals USA, INC. | $140.30 | 2019 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Breuder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.